Belgium, land of investment opportunity for biopharmaceuticals

Belgium is the birthplace of several world research centres for the biopharmaceutical industry. Belgian laboratories developed drugs and vaccines for the major world pandemics (HIV/AIDS, tuberculosis, malaria, etc.). World renowned pharmaceutical companies have invested tens of billions of euros in our country over the past few years. In absolute figures, Belgium is also the world’s leading export country for drugs.

There are, therefore, many solid reasons to promote Belgium as an attractive land of investment opportunity for the (bio)pharmaceutical industry.

Read more

Belgian federal government strengthens its financial position in the KBC group

Versterking KBC-groep

The KBC group and the Belgian federal government reached an agreement, on Monday, 27 October 2008, in a bid to strengthen the bank insurer's capital base by Euro 3.5 billion. The capital injection will boost the bank's Core Tier-1.

read more

Fortis: additional measures

illustration

Consistent with the agreement reached on Sunday 28 September concerning the rising involvement of the Belgian, Dutch and Luxembourg States in the Fortis Group, the Belgian government in consultation with the Luxembourg government, has decided to implement additional measures aimed at ensuring the lasting solvability of Fortis Banque.

read more

Latest news

More news